Jason A. Leverone

Chief Financial Officer

Chief Financial Officer at OnKure Therapeutics, Inc., filing insider transactions between 2026-03-23 and 2026-06-22.

Total Purchases

—

0 transactions

Total Sales

$3K

2 transactions

Companies Traded

2 total filings

Active Since

2026-03-23

Last: 2026-06-22

Companies

OnKure Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-22	OKUR	Sale	303	$4.40	$1K	18.8K	SEC ↗
2026-03-23	OKUR	Sale	301	$4.16	$1K	16.0K	SEC ↗